What Nobody Tells You About Supplement Marketing: Why We Say "Supports" Instead of "Treats"

Every supplement label in America carries the same disclaimer: "This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease." Most people skip it. The ones who read it assume it's legal boilerplate. It's not. It's the single most important sentence in the supplement industry — and understanding why it's there will change how you buy vitamins forever.

I run a sublingual strip company. That means I spend an uncomfortable amount of time thinking about the words on our labels, the claims in our emails, and whether the science behind every statement could survive a room full of hostile regulators. This isn't a marketing strategy. It's a founder's compulsion — and if more supplement companies operated this way, you wouldn't need this article.

Here's the thing nobody in the industry wants to explain to you: the language on your supplement labels is legally constrained in ways that most consumers completely misunderstand. And that misunderstanding is exactly what dishonest brands exploit.

The Law Behind the Label: What DSHEA Actually Says

In 1994, Congress passed the Dietary Supplement Health and Education Act — DSHEA — which created the regulatory framework every supplement company operates under today. The law drew a bright line between two types of claims:

Structure/function claims describe how a nutrient affects the normal structure or function of your body. "Calcium builds strong bones." "Supports immune health." "Helps maintain healthy blood sugar levels already within the normal range." These are legal for supplements.

Disease claims assert that a product diagnoses, treats, cures, mitigates, or prevents a specific disease. "Treats arthritis." "Prevents heart disease." "Cures diabetes." These are reserved exclusively for FDA-approved drugs.

The distinction sounds simple. It's not. "Supports a healthy inflammatory response" is a structure/function claim. "Reduces inflammation" drifts into disease territory because inflammation is tied to specific medical conditions. Even implied disease connections count — an image of a healthy heart next to the wrong claim language can cross the line.

This is why we say "supports" instead of "treats." Not because we're being coy. Because the law requires it — and the law exists to protect you from companies claiming their turmeric capsule cures cancer.

The Part That Should Bother You: Nobody Checks Before You Buy

Here's the fact that genuinely surprised me when I started this company: FDA does not approve supplement claims before products hit shelves.

Under DSHEA, a manufacturer must notify FDA of a structure/function claim within 30 days after first marketing the product. That notification contains the claim text only — not the evidence supporting it. FDA never sees the substantiation data. It never reviews the studies. It never says "yes, this claim is valid." The product is already in your Amazon cart before the agency even learns the claim exists.

Compare that to pharmaceuticals, where a new drug application requires years of clinical trials, FDA review, and explicit premarket approval before a single pill reaches a pharmacy.

The substantiation standard itself is vague: manufacturers must hold "competent and reliable scientific evidence" that their claims are truthful and not misleading. But what constitutes "competent and reliable" is never precisely defined by FDA. The FTC, which regulates supplement advertising (as opposed to labeling), tightened this in December 2022 with updated Health Products Compliance Guidance stating that health-benefit claims generally need substantiation from randomized, controlled human clinical trials. But that applies to ads, not labels — and enforcement is reactive, not preventive.

What this means in practice: any company can put almost any structure/function claim on a supplement label, sell the product, and only face consequences if and when a regulator decides to investigate.

Enforcement Is Real — But It Happens After You've Already Bought the Product

The system isn't lawless. The consequences for crossing the line are severe — they just arrive late.

In March 2025, FDA and FTC jointly sent warning letters to 10 companies illegally marketing dietary supplements with claims to treat, cure, or prevent diabetes. These weren't obscure products — they were supplements making explicit disease claims that had been on sale long enough to reach thousands of consumers before regulators intervened.

The FTC's enforcement arm has teeth. In November 2024, the agency completed a $536,000 refund to more than 56,000 consumers who bought Sobrenix, a supplement marketed as reducing or eliminating alcohol cravings — a disease claim the company couldn't substantiate. The defendants were permanently banned from making unsubstantiated health claims. In July 2025, $409,000 in refunds went to consumers who bought Roca Labs weight-loss supplements based on deceptive claims.

The FTC has also sent "Notice of Penalty Offenses" to roughly 700 supplement marketers, warning them that unsubstantiated claims now carry civil penalties of $50,000+ per violation.

But notice the pattern: every one of these actions happened after consumers spent money on products that didn't do what the labels suggested. The system catches bad actors eventually. It doesn't prevent them from reaching you first.

Consumers Hear "Treats" When Labels Say "Supports"

This is the part that keeps me up at night as a founder who actually cares about what we put on our labels.

A September 2025 study published in JAMA Network Open surveyed 4,403 U.S. adults, showing them supplement labels with standard structure/function language like "heart health" or "brain health." The finding was damning: participants who saw these common label statements were significantly more likely to believe the supplement prevented or treated cardiac and neurological diseases.

Read that again. The exact language the law requires supplement companies to use — "supports heart health" instead of "treats heart disease" — is being systematically misread by consumers as a disease treatment claim. The mandatory FDA disclaimer ("not intended to diagnose, treat, cure, or prevent any disease") did little to correct the impression.

The researchers' conclusion: commonly used label statements "exceed the scope of their intended meaning," and the labeling regulations need reevaluation.

This creates a perverse incentive. Honest companies that carefully word their claims to stay within the law are still inadvertently creating disease-claim impressions. Dishonest companies know consumers will hear "treats" regardless — so they push the language as close to the line as possible, knowing the ambiguity works in their favor.

What We Actually Do About It (And What the Industry Should)

At XYNE, our approach is simple: if we can't cite the study, we don't make the claim.

Every number on our site traces back to a peer-reviewed journal, an NIH fact sheet, or a Mayo Clinic reference. When we say sublingual B12 delivers approximately 28% bioavailability compared to ~1.2% for oral cyanocobalamin, that comes from Sharabi 2003 in the British Journal of Clinical Pharmacology and the NIH Office of Dietary Supplements B12 Fact Sheet. When we say oral glutathione supplementation didn't significantly raise glutathione levels in one crossover trial but sublingual delivery did, that's Schmitt et al. 2015 in Redox Biology.

And when the evidence doesn't support a sublingual advantage, we say so. Calcium is a pill. Magnesium is a pill. Gut-colonizing probiotics need a capsule to survive transit. Creatine needs gram-level dosing that can't physically fit in a strip. We've published an entire article about exactly where sublingual delivery works and where it doesn't — because being the honest brand in a dishonest industry is the only competitive advantage that compounds over time.

This is the routine I'd put my mom on. And my mom doesn't need marketing — she needs the truth.

How to Read Supplement Marketing Like a Skeptic

You shouldn't need a regulatory background to buy vitamins. But until the system changes, here's what to watch for:

Check the claim language. "Supports healthy blood sugar levels" is a legal structure/function claim. "Lowers blood sugar" or "helps manage diabetes" is a disease claim — and a supplement making that statement is either breaking the law or relying on your ignorance of the distinction.

Look for specific citations. "Clinically proven" without a journal name, year, and study size is meaningless. Any company can write "clinically proven" — the question is whether they'll show you the study. If the evidence section on a supplement company's website is shorter than the testimonials section, that tells you where their confidence actually comes from.

Check for third-party testing. USP (United States Pharmacopeia) and NSF International are the gold standards for independent verification. They audit facilities, test finished products, and require ongoing compliance. ConsumerLab.com buys products off shelves and publishes pass/fail results. These certifications are voluntary — no law requires them — and only a minority of supplement brands carry them. A 2023 study in JAMA found that 22 of 25 melatonin gummy products (88%) were inaccurately labeled, with actual melatonin content ranging from 74% to 347% of what the label claimed. One product contained no melatonin at all — it had CBD instead.

Be suspicious of format claims. "Dissolves in your mouth" does not mean "absorbed in your mouth." Many orodispersible tablets and films disintegrate orally but are still swallowed and absorbed through the gut — the dissolution is a convenience feature, not a delivery advantage. We've written about the real format science because the distinction matters, and most format marketers gloss over it entirely.

When to Ignore the Supplement and See a Doctor

No amount of honest marketing changes the fundamental truth: supplements support health. They don't treat disease. And the gap between those two things is where people get hurt.

If you're experiencing symptoms — persistent fatigue, unexplained weight changes, mood disruptions that interfere with daily life, chronic pain, or anything that feels medically wrong — the answer is a physician, not a supplement. No strip, pill, capsule, powder, or gummy replaces a diagnosis.

This is the defensive paragraph most supplement companies skip. It doesn't help sell product. It does help keep people safe. And if you're reading this on the blog of a company that makes supplements, take that as a signal of the kind of brand we're trying to build.

The Industry Can Do Better. Here's What "Better" Looks Like.

I don't think DSHEA needs to be repealed. The structure/function claim framework protects consumers from unproven disease claims while allowing truthful communication about what nutrients do. The problem is enforcement timing and transparency gaps:

Pre-market claim review would change everything. If FDA reviewed structure/function claims before products shipped — even with a fast-track 60-day review — the "claim now, defend later" business model would collapse overnight.

Mandatory third-party testing would fix label accuracy. The 88% inaccuracy rate in melatonin gummies isn't a labeling problem — it's a manufacturing and verification problem. Making USP or NSF certification a requirement rather than a voluntary badge would eliminate the worst actors.

Plain-language claim disclosures would close the perception gap. The JAMA Network Open study showed that the current FDA disclaimer doesn't work. A simpler statement — something like "This supplement has not been proven to treat any medical condition" — might bridge the gap between what labels say and what consumers hear.

Until any of that happens, the responsibility falls on individual brands. And the brands that take it seriously are the ones that explain the system to you instead of exploiting it.

FAQ

Why do supplement labels always say "supports" instead of "treats" or "cures"?

Federal law — specifically the Dietary Supplement Health and Education Act (DSHEA) of 1994 — prohibits supplements from making disease claims. Only FDA-approved drugs can claim to diagnose, treat, cure, or prevent disease. Supplements may only make "structure/function claims" describing how a nutrient affects normal body function. "Supports immune health" is legal; "treats infections" is not. The mandatory disclaimer on every supplement label reflects this distinction.

Does the FDA approve supplement claims before products go on sale?

No. Under current law, manufacturers notify FDA of structure/function claims within 30 days after first marketing. The notification includes only the claim text — not the supporting evidence. FDA never pre-approves supplement claims, and never reviews the substantiation data unless it opens an investigation.

How can I tell if a supplement brand is being honest about its claims?

Look for specific, cited evidence (journal names, study sizes, publication years) rather than vague "clinically proven" language. Check for third-party testing certifications (USP, NSF). Watch whether the company acknowledges limitations of its own products — honest brands explain when their format or ingredient isn't the right choice. And verify that all claims stay in structure/function territory ("supports," "helps maintain") rather than crossing into disease claims ("treats," "cures," "prevents").

Are structure/function claims reliable?

The claims themselves are legal — but a 2025 JAMA Network Open study of 4,403 adults found that consumers systematically interpret them as disease treatment claims. The regulatory framework is well-intentioned, but the gap between legal language and consumer understanding is real. Your best protection is looking past the claim to the evidence behind it.

What happens to companies that make false supplement claims?

The FTC and FDA investigate and enforce. Recent actions include $536,000 in consumer refunds for Sobrenix (unsubstantiated alcohol-craving claims, 2024), $409,000 in refunds for Roca Labs (deceptive weight-loss claims, 2025), and joint FDA/FTC warning letters to 10 companies making diabetes treatment claims (March 2025). Penalties can exceed $50,000 per violation. However, enforcement is reactive — it happens after consumers have already purchased the products.

Related Reading

• Sublingual vs. Oral Supplements: The Format Comparison
• Bioavailability Explained: Why Format Determines What You Absorb
• The Honest Science of Sublingual Absorption: What Works and What's Marketing
• Glutathione Absorption: Why Your Pills Are Basically Useless
• Pill Fatigue Is Real: Why 40% of Users Are Ditching Capsules
• Sugar-Free Supplement Options: What "No Added Sugar" Means in the Strip Format

*These statements have not been evaluated by the Food and Drug Administration. XYNE products are not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.